GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: cis-JB253 is described in [1]. The structure is based upon that of the diabetes sulfonylurea drug glimepiride. This compound is formed from trans-JB253 upon photoisomerization using blue light. This isomerization process is reversible. The molecule is active in the cis-state, increasing insulin production from pancreatic B-cells in vitro. It is postulated that this type of photoswitchable compound could in the future, allow better control of blood glucose in diabetic patients [1].
Note that the PubChem CID we link to does not specify the cis-trans state of the compound. |
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 1-cyclohexyl-3-{4-[(Z)-2-[4-(diethylamino)phenyl]diazen-1-yl]benzenesulfonyl}urea |
Database Links ![]() |
|
| GtoPdb PubChem SID | 223366119 |
| PubChem CID | 78060683 |
| Search Google for chemical match using the InChIKey | FCHDFDWESRUUDK-QPLCGJKRSA-N |
| Search Google for chemicals with the same backbone | FCHDFDWESRUUDK |
| UniChem Compound Search for chemical match using the InChIKey | FCHDFDWESRUUDK-QPLCGJKRSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | FCHDFDWESRUUDK-QPLCGJKRSA-N |